Materialise NV (MTLS) 股票分析
科技Materialise NV
$6.19
+$0.29 (+4.92%)
最后更新: 2026年5月26日
价格走势
暂无价格数据
分析
公司概述
Materialise NV operates as a technology provider within the software application industry, delivering additive manufacturing solutions, medical software tools, and 3D printing services across the Americas, Europe, Africa, and the Asia-Pacific regions. The company structures its operations through three distinct segments: Materialise Software, Materialise Medical, and Materialise Manufacturing, each targeting specific verticals within the industrial and healthcare markets. As of the latest reporting period, the firm holds a market capitalization of $324.40M and generates annual revenue of $267.63M, though specific employee count data is not disclosed in available records. These valuation and revenue figures position Materialise as a mid-cap entity in the specialized technology sector, indicating a company that has achieved significant revenue scale while maintaining a relatively modest market valuation compared to large-cap peers.
财务健康
The company reported revenue of $267.63M over the trailing twelve months, with net income of $7.72M and EBITDA reaching $30.64M, highlighting a structural gap where operating profitability before interest and taxes exceeds net income by a significant margin. This disparity between EBITDA and net income suggests that the cost structure includes substantial interest expenses, taxes, or non-operating costs that materially reduce the bottom line relative to cash earnings. Free cash flow for the period was recorded at -$1,316,000, indicating a temporary cash burn that limits immediate financial flexibility for capital expenditures or unexpected liabilities without external financing. Gross margin stands at 57.1%, reflecting high pricing power or low cost of goods sold typical of software and specialized hardware integration, while the operating margin of 4.4% and profit margin of 2.9% indicate that overhead costs and other expenses consume a large portion of gross profits before reaching the net bottom line. On the balance sheet, the company holds $133.92M in cash against $63.11M in debt, supported by a debt-to-equity ratio of 24.70 which, despite the high numerical value, is mitigated by the substantial cash reserve. The current ratio is 2.43, signaling a conservative short-term liquidity position where current assets are more than double current liabilities. Return on equity is 3.1% and return on assets is 1.4%, metrics that reveal management effectiveness is currently constrained by the scale of the asset base and the modest profitability relative to the invested capital.
估值评估
The trailing twelve-month P/E ratio is 33.47, while the forward P/E is significantly lower at 19.77, implying that the market expects earnings growth to be substantial enough to justify a lower multiple in the coming year. The price-to-book ratio is 1.00, indicating that the stock trades at par value relative to its book value, suggesting the market does not currently assign a significant premium for intangible assets or future growth potential in this calculation. Price-to-sales stands at 1.21 and EV/EBITDA is 7.36, offering alternative perspectives where the sales multiple reflects a revenue-heavy valuation model common in software firms, while the EV/EBITDA suggests the enterprise value is priced at a discount relative to operating cash generation. Over the past year, the stock has fluctuated between a 52-week high of $6.80 and a 52-week low of $4.08, trading dynamics that place the current price within a range that reflects both volatility and potential downside protection. The beta is 1.20, meaning the stock exhibits 20% higher volatility than the broader market, which increases risk for risk-averse investors but may offer higher expected returns during bull markets.
Growth & Income
Revenue growth for the trailing twelve months was 6.8%, while earnings growth surged to 112.8%, demonstrating that earnings are expanding at a rate far faster than revenue, likely due to margin expansion or one-time adjustments. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, indicating a strategy of reinvesting all earnings back into the business for expansion or research and development rather than returning capital to shareholders. This reinvestment approach aligns with the high earnings growth rate, prioritizing long-term scalability over immediate income generation for shareholders. Overall, the growth and income profile characterizes Materialise as a capital-reinvestment focused growth company with no current income distribution but accelerating earnings performance relative to its top-line expansion.
同行比较
Materialise NV (MTLS) 在软件 - 应用程序行业运营。以下是其与市值最接近的同行的比较:
| 公司 | 代码 | 市值 | 市盈率 |
|---|---|---|---|
| Materialise NV | MTLS | $344.08M | 29.5 |
| SAP SE | SAP | $206.49B | 24.1 |
| Shopify Inc. | SHOP.TO | $188.02B | 102.8 |
| Salesforce, Inc. | CRM | $146.50B | 22.9 |
软件 - 应用程序行业平均市盈率为45.6倍。Materialise NV的市盈率为29.5。
本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。
相关软件 - 应用程序股票
SAP SE
$206.49B
SHOP.TOShopify Inc.
$188.02B
CRMSalesforce, Inc.
$146.50B
UBERUber Technologies, Inc.
$142.74B
SHOPShopify Inc.
$136.12B
NOWServiceNow, Inc.
$105.33B
科技热门股票
NVIDIA Corporation
$6.77T
AAPL.TOApple Inc.
$5.97T
NVDANVIDIA Corporation
$5.22T
AAPLApple Inc.
$4.53T
MSFT.TOMicrosoft Corporation
$4.10T
关于Materialise NV
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
公司简介以英文显示。
访问官网 →